Toenail selenium concentration and lung cancer in male smokers (Finland)
Authors:
Terryl J. Hartman, Philip R. Taylor, Georg Alfthan, Richard Fagerstrom, Jarmo Virtamo, Steven D. Mark, Mikko Virtanen, Michael J. Barrett, Demetrius Albanes
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.